P. Blanco

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release

E. Levy, J. Mordoh, M. M. Barrio, 2017, Front. Immunol..

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

P. Yankilevich, E. Levy, J. Mordoh, 2018, Front. Immunol..

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood

M. Nielsen, J. Mordoh, M. M. Barrio, 2019, Front. Immunol..

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

E. Levy, J. Mordoh, M. M. Barrio, 2017, Front. Immunol..

Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine.

J. Mordoh, J. Arriaga, M. M. Barrio, 2012, Cryobiology.

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants

E. Levy, J. Mordoh, G. Cueto, 2018, Front. Immunol..

Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine.

J. Mordoh, J. Arriaga, M. M. Barrio, 2012, Cryobiology.